You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Details for Patent: 8,470,871


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,470,871 protect, and when does it expire?

Patent 8,470,871 protects AKLIEF and is included in one NDA.

This patent has twenty-seven patent family members in twenty-three countries.

Summary for Patent: 8,470,871
Title:Ligands that modulate RAR receptors
Abstract: Novel ligand compounds having the general formula (I): ##STR00001## and pharmaceutical/cosmetic compositions comprised thereof are useful in human and veterinary medicine or, alternatively, in cosmetics.
Inventor(s): Biadatti; Thibaud (Opio, FR), Dumais; Laurence (Le Rouret, FR), Soulet; Catherine (Antibes, FR), Talano; Sandrine (Vence, FR), Daver; Sebastien (Antibes, FR)
Assignee: Galderma Research & Development (Biot, FR)
Application Number:13/527,299
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 8,470,871

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Galderma Labs Lp AKLIEF trifarotene CREAM;TOPICAL 211527-001 Oct 4, 2019 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial METHOD OF ACTIVATING RARGAMMA RECEPTOR ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,470,871

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France04/13848Dec 23, 2004

International Family Members for US Patent 8,470,871

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 055297 ⤷  Try a Trial
Austria E542791 ⤷  Try a Trial
Australia 2005318292 ⤷  Try a Trial
Brazil PI0517500 ⤷  Try a Trial
Canada 2590246 ⤷  Try a Trial
China 101087752 ⤷  Try a Trial
Cyprus 1112721 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.